Abstract
Jenkinson CP, Tripathy DT, Cromack DT, Curran JE, Kumar S, Carless M, Abdul-Ghani M, Puppala S, Arya R, Dyer TD, Lehman DM, Hu SL, Fourcaudot M, Norton L, Farook VS, Blangero J, Goring HH, DeFronzo RA, Duggirala R. Transcriptomic Identification of ADH1B as a Candidate Gene for Obesity and Insulin Resistance in Human Adipose Tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES); 2015 Jan. (Diabetes). Chavez A, Vinales K, Mendoza-Guardado R, Alonzo R, Hansis-Diarte A, DeFronzo R, Tripathy D. Differential Effect of Pioglitazone, Exenatide, and Combination of Pioglitazone and Exenatide on Plasma Metabolites in Type 2 Diabetes; 2015 Jan. (Diabetes). Iozzo P, Giuseppe D, Molina-Wilkins M, Ciociaro D, Lancaster J, Triplit C, Cersosimo E, Fx P, Musi N, Tripathy D, Defronzo R, Gastadelli A. A Better Antilipolytic Effect of Insulin and Reduced Adipose Tissue Glucose Uptake after Exenatide Injection during PET-OGTT; 2015 Jan. (Diabetes). Espinoza S, Wnag Chen-Pin, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi A, Mudaliar S, Ratner R, Reaven P, Schwenke D, Stenz F, DeFronzo RA, Tripathy D, Musi N. Pioglitazone Is Equally Effective for Diabetes Prevention in Older Compared with Younger Prediabetic Adults; 2015 Jan. (Diabetes). Daniele G., Perez-Cadena Z., Chavez-Velasquez A., Kamath S., Zuo P., Chang Z., Andreozzi F., Paez A., Fourcaudot M., Winnier D., Hansis-Diarte A., Jenkinson C., Fanti P., Gastaldelli A., DeFronzo R., Tripathy D., Folli F. Low-dose (15 mg/day) pioglitazone treatment improves glycemic and sub-inflammatory state in obese type 2 diabetic subjects in 24 week intervention study; 2012 Jan. (ADA Meeting).
Book Chapter
Tripathy D. Is this type 2 diabetes, type 1 diabetes, or late autoimmune diabetes in adults?. In: Tripathy D, Pinkson S, Koops M, DeFronzo RA. Diabetes Case Studies. Draznin B, Low Wang CC, Rubin DJ, Eds. Alexandria, VA, American Diabetes Association, Diabetes Case Studies 2: American Diabetes Association, Draznin B, Low Wang CC, Rubin DJ, Eds; 2015. p. 64-66.
Journal Article
Danielle G, Iozzo P, Molina-Wilkins M, Lancaster J, Ciociaro D, Triplitt C, Cersosimo E, Tripathy D, Fox P, Musi N, DeFronzo RA, Gastaldelli A. Exenatide Affects the Distribution of Cerebral Postprandial Glucose Uptake: (in press) Diabetes 2015 Jan;. Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, Emanuele NV; VADT Investigators. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes N Engl J Med 2015 Jan;372(23):2197-2206. Tripathy D, Cobb JE, Gall W, Adam KP, Georgete T, Schwenke D, Clement S, Banerji MA, Bray GA, Buchanan TA, Henry RR, Kitabchi A, Mudaliar S, Musi N, Ratner R, Reaven P, Stenz F, and Reaven P, DeFronzo RA. A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACTNOW study. (in press) J Clin Endocrinol Metab 2015 Jan;. Daniele G, Eldor R, Merovci A, Clarke GD, Xiong J, Tripathy D, Taranova A, Abdul-Ghani M, Defronzo RA. Chronic Reduction of Plasma FFA Improves Mitochondrial Function and Whole Body Insulin Sensitivity in Obese and Type 2 Diabetic Individuals Diabetes 2014 Jan;63(8):2812-2820. Tripathy D, Clement S, Schwenke D Banerji MA, Bray GA, Buchanan TA, Henry RR, Kitabchi A, Mudaliar S, Musi N, Ratner R, Reaven P, Stenz F, and Reaven P,. Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW Diabetes Care 2014 Jan;37(6):1706-1711. Tripathy D, Daniele G, Fiorentino TV, Perez-Cadena Z, Chavez-Velasquez A, Kamath S, Fanti P, Jenkinson C, Andreozzi F, Federici M, Gastaldelli A, Defronzo RA, Folli F. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study Diabetologia 2013 Oct;56:2153-2163. Abdul-Ghani MA, Muller FL, Liu Y, Chavez AO, Balas B, Zuo P, Chang Z, Tripathy D, Jani R, Molina-Carrion M, Monroy A, Folli F, Van Remmen H, DeFronzo RA, Abdul-Ghani M. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance Am J Physiol Endocrinol Metab 2008 Sep;295(3):678-685.
